Cargando…

Fifteen new nucleotide substitutions in variants of human papillomavirus 18 in Korea: Korean HPV18 variants and clinical manifestation

High-risk human papillomavirus (HPV) infection is an essential factor for the development of cervical cancer. HPV18 is the second most common carcinogenic HPV type following HPV16, but the lineages of HPV18 have been less well studied than those of HPV 16. The purpose of this study was to analyze th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Namhee, Park, Jeong Su, Kim, Ji Eun, Park, Jae Hyeon, Park, Hyunwoong, Roh, Eun Youn, Yoon, Jong Hyun, Shin, Sue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245819/ https://www.ncbi.nlm.nih.gov/pubmed/32448303 http://dx.doi.org/10.1186/s12985-020-01337-7

Ejemplares similares

Human Papillomavirus (HPV) genotype 18 variants in patients with clinical manifestations of HPV related infections in Bilbao, Spain
por: Arroyo, Sara L, et al.
Publicado: (2012)

Can human papillomavirus (HPV) genotyping classify non-16/18 high-risk HPV infection by risk stratification?
por: Sung, Yeoun Eun, et al.
Publicado: (2016)

Differences in the diagnosis and treatment of hematologic malignancies attributable to health insurance coverage
por: Song, Eun Young, et al.
Publicado: (2022)

The use of a borderline zone for the interpretation of interferon-gamma release assay results for serial screening of healthcare workers
por: Park, Jae Hyeon, et al.
Publicado: (2020)

Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs
por: Yun, Jiwon, et al.
Publicado: (2021)

Positivity of SARS-CoV-2 Antibodies among Korean Healthy Healthcare Workers 1 and 2 Weeks after Second Dose of Pfizer-BioNTech Vaccination
por: Kim, Namhee, et al.
Publicado: (2021)

Strong SARS-CoV-2 Antibody Response After Booster Dose of BNT162b2 mRNA Vaccines in Uninfected Healthcare Workers
por: Kwon, Seok Ryun, et al.
Publicado: (2022)

Evaluation of Five User-Friendly Whole Genome Sequencing Software for Mycobacterium tuberculosis in Clinical Application
por: Kim, Namhee, et al.
Publicado: (2022)

HPV 18 variants in women with cervical cancer in Northeast Brazil
por: Santos, Gerusinete Rodrigues Bastos dos, et al.
Publicado: (2022)

Phylogeny and Classification of Human Papillomavirus (HPV)16 and HPV18 Variants Based on E6 and L1 genes in Tunisian Women with Cervical Lesions
por: Jendoubi-Ferchichi, Mouna, et al.
Publicado: (2018)

Association between HOX Transcript Antisense RNA Single-Nucleotide Variants and Recurrent Implantation Failure
por: Lee, Jeong Yong, et al.
Publicado: (2021)

A Low Density Microarray Method for the Identification of Human Papillomavirus Type 18 Variants
por: Meza-Menchaca, Thuluz, et al.
Publicado: (2013)

Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors
por: Damm, Oliver, et al.
Publicado: (2009)

Barriers to human papillomavirus (HPV) vaccination among young adults, aged 18–35
por: Muthukrishnan, Meera, et al.
Publicado: (2022)

Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada
por: Kohli, Michele, et al.
Publicado: (2012)

(18)F-THK5351 PET Imaging in the Behavioral Variant of Frontotemporal Dementia
por: Nam, Gijin, et al.
Publicado: (2018)

Screening and detection of human papillomavirus (HPV) high-risk strains HPV16 and HPV18 in saliva samples from subjects under 18 years old in Nevada: a pilot study
por: Flake, Colton, et al.
Publicado: (2012)

Evaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening
por: BIAN, MEI-LU, et al.
Publicado: (2013)

Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18
por: Bogaards, Johannes A, et al.
Publicado: (2019)

Characteristics of human papillomavirus infection among females and the genetic variations of HPV18 and HPV58 in Henan province, China
por: Wang, Ying, et al.
Publicado: (2023)

Phytoconstituents of traditional Himalayan Herbs as potential inhibitors of Human Papillomavirus (HPV-18) for cervical cancer treatment: An In silico Approach
por: Salaria, Deeksha, et al.
Publicado: (2022)

Spectrum of MNX1 Pathogenic Variants and Associated Clinical Features in Korean Patients with Currarino Syndrome
por: Lee, Seungjun, et al.
Publicado: (2018)

Analysis of Sequence Variation and Risk Association of Human Papillomavirus 52 Variants Circulating in Korea
por: Choi, Youn Jin, et al.
Publicado: (2016)

Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul, South Korea
por: Han, Mi Seon, et al.
Publicado: (2020)

Persistence of human papillomavirus 16, 18 and 52 variants in Inuit women from Northern Quebec, Canada
por: Gauthier, Barbara, et al.
Publicado: (2019)

Ancient Evolutionary History of Human Papillomavirus Type 16, 18 and 58 Variants Prevalent Exclusively in Japan
por: Tanaka, Kohsei, et al.
Publicado: (2022)

Cervical intraepithelial neoplasia 3, coinfected with HPV-16 and -18--case report.
por: Park, J. S., et al.
Publicado: (1993)

Comparison of Seegene Anyplex II HPV28 assay with BD Onclarity HPV assay for human papillomavirus genotyping
por: Kim, Moonsik, et al.
Publicado: (2022)

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)

Prevalence of granular corneal dystrophy type 2-related TGFBI p.R124H variant in a South Korean population
por: Park, Jong Eun, et al.
Publicado: (2021)

In North America, Some Ovarian Cancers Express the Oncogenes of Preventable Human Papillomavirus HPV-18
por: Roos, Patrick, et al.
Publicado: (2015)

Frequency of Human Papillomavirus (HPV) 16 and 18 Detection in Paraffin- Embedded Laryngeal Carcinoma Tissue
por: Hosseini, Seyed Zinab, et al.
Publicado: (2017)

Carcinogenic risk of human papillomavirus (HPV) genotypes and potential effects of HPV vaccines in Korea
por: Park, Eunhyang, et al.
Publicado: (2019)

Variants of human papillomaviruses 16 (HPV16) in Uigur women in Xinjiang, China
por: He, Hongchang, et al.
Publicado: (2016)

Is human papillomavirus genotype an influencing factor on radiotherapy outcome? Ambiguity caused by an association of HPV 18 genotype and adenocarcinoma histology
por: Kim, Joo-Young, et al.
Publicado: (2011)

Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand
por: Khunamornpong, Surapan, et al.
Publicado: (2016)

Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus–Based Screening in Mexico
por: Torres-Ibarra, Leticia, et al.
Publicado: (2019)

Clinical Significance of an HPV DNA Chip Test with Emphasis on HPV-16 and/or HPV-18 Detection in Korean Gynecological Patients
por: Yeo, Min-Kyung, et al.
Publicado: (2016)

Evaluation of the characteristics of multiple human papillomavirus (HPV) infections identified using the BD Onclarity HPV assay and comparison with those of single HPV infection
por: Kim, Jinhee, et al.
Publicado: (2022)

Clinically refined epidemiology of nontuberculous mycobacterial pulmonary disease in South Korea: overestimation when relying only on diagnostic codes
por: Park, Jae Hyeon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p2qajiin3isbvgc5fh5hhje45n